Intraperitoneal Bevacizumab for Control of Malignant Ascites Due to Advanced-Stage Gastrointestinal Cancers: A Multicentre Double-Blind, Placebo-Controlled Phase Ii Study - Aio Sup-0108
AuthID
P-00K-JKM
P-00K-JKM